News
PASI-75 with ixekizumab approaches 90% in pediatric psoriasis study
MADRID – The results bode well for an underserved population.
News
Starting PCSK9 inhibitor in acute-phase ACS under study
PARIS – LDL cholesterol lowering is massive, but what about impact on clinical events?
News
Adolescent lung inflammation may trigger later MS
STOCKHOLM – Swedish national health care registry studies show associations between pneumonia or infectious mononucleosis occurring in early...
News
Smoking impairs cognition and shrinks brain volume in MS
STOCKHOLM – New evidence suggests the damage may be partially reversible.
News
Major survey spotlights novel factors influencing acne
MADRID – Do you ask your acne patients if they use cannabis?
News
No tacrolimus/cancer link in atopic dermatitis in 10-year study
MADRID – When will the boxed warning get the boot?
News
Food addiction is pervasive among psychiatric patients
COPENHAGEN – Food addiction may be a key link between psychiatric disease, obesity, and reduced life expectancy.
News
Spotlight is on promising investigational antipsychotics
COPENHAGEN – The focus is on the unmet need for better treatments for negative symptoms of schizophrenia.
News
Remote ischemic conditioning in STEMI, RIP
PARIS – The definitive randomized CONDI-2/ERIC-PPCI trial shows no reduction in cardiac mortality or heart failure.
News
Certain diabetes drugs may thwart dementia
COPENHAGEN – Intriguing findings from a Danish national registry study.
News
Once-daily oral JAK inhibitor for atopic dermatitis effective in phase 3 study
MADRID – “One day after taking the first pill, you can see really nice reductions in itch at both doses, compared with placebo.”
News
Rituximab bests mycophenolate in pemphigus vulgaris
MADRID – “Rituximab has a superior overall benefit/risk profile, compared to mycophenolate mofetil, in patients with moderate to severe pemphigus...
News
Psoriasis registry data provide evidence that adalimumab reduces mortality
MADRID – The 10-year results from the real-world ESPRIT registry paint a highly favorable picture.
News
New themes emerging about antipsychotic maintenance therapy
COPENHAGEN – “Polypharmacy might not be so bad.” – Dr. Mark Weiser